Zentalis Pharmaceuticals, Inc. (ZNTL) Operating income 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual operating income history from SEC filings — each fiscal year as reported.
-$152.8MFY2025 · since FY2019: -$46.8M → -$152.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$152.8M | +20.1% |
| FY2024 | -$191.2M | +36.2% |
| FY2023 | -$299.5M | -31.8% |
| FY2022 | -$227.3M | -5.0% |
| FY2021 | -$216.5M | -82.3% |
| FY2020 | -$118.8M | -153.6% |
| FY2019 | -$46.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice